๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Key Issues in Multidrug-Resistant Tuberculosis

โœ Scribed by Biswajit Chakrabarti; Peter D. O. Davies

Publisher
John Wiley and Sons
Year
2007
Weight
11 KB
Volume
38
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Multidrug resistance in ovarian cancer
Multidrug resistance in ovarian cancer
โœ Antonio Fojo; Thomas C. Hamilton; Robert C. Young; Robert F. Ozols ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 687 KB

The development of acquired resistance has limited the effectiveness of chemotherapy in the treatment of ovarian cancer. Experimental model systems were developed to study the mechanisms associated with primary resistance to chemotherapeutic agents and broad cross-resistance (multidrug resistance) w

New Strategies Combating Bacterial Infec
New Strategies Combating Bacterial Infection || Promising Current Drug Candidates in Clinical Trials and Natural Products Against Multidrug-Resistant Tuberculosis
โœ Ahmad, Iqbal; Aqil, Farrukh ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Wiley-VCH Verlag GmbH & Co. KGaA ๐ŸŒ German โš– 305 KB ๐Ÿ‘ 1 views

Combating bacterial infections calls for a multidisciplinary approach and this is what is on offer here. Written by an experienced international team of researchers from various fields ranging from biotechnology to traditional medicine, the book provides complete and comprehensive coverage of topics

Gene amplification in multidrug-resistan
Gene amplification in multidrug-resistant cells: Molecular and karyotypic events
โœ Andrey Gudkov; Boris Kopnin ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 659 KB

## Multidrug resistance (MDR) is developed in a population of somatic mammalian cells in vivo or in vitro when they are selected for resistance to each of a large group of drugs (colchicine, adriamycin, actinomycin D , etc.). It isproduced by the amplification of some unknown gene@) whose praduct(s)